(Q41063096)

26 September 2017

1 reference

title

Ovarian hyperstimulation syndrome may be more likely if multiple pregnancy occurs following assisted conception (English)

1 reference

ovarian hyperstimulation syndrome

26 September 2017

main subject

1 reference

Mathur RS

1

1 reference

26 September 2017

Joels LA

series ordinal

2

1 reference

26 September 2017

Jenkins JM

series ordinal

3

1 reference

26 September 2017

publication date

1 January 1995

1 reference

Acta geneticae medicae et gemellologiae

26 September 2017

published in

1 reference

26 September 2017

volume

44

1 reference

26 September 2017

issue

3-4

1 reference

26 September 2017

page(s)

233-235

1 reference

The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features.

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

Ovarian hyperstimulation syndrome: a review of pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

In vitro fertilization and the ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

7 January 2021

The predictive value of a single beta human chorionic gonadotropin in pregnancies achieved by assisted reproductive technology

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

7 January 2021

Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

7 January 2021

Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

7 January 2021

Plasma prorenin in first-trimester pregnancy: relationship to changes in human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

7 January 2021

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

7 January 2021

The management of severe ovarian hyperstimulation syndrome

1 reference

https://api.crossref.org/works/10.1017%2FS0001566000001653

7 January 2021

10.1017/S0001566000001653

Identifiers

DOI

1 reference

26 September 2017

1 reference